Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance
NCT01191099
·
clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DEVICE:
Pimonidazol
Sponsor
University of Zurich